title: Consequences of increasing or decreasing plasma FSH concentrations during the preovulatory period in Romney ewes.
abstract: Romney ewes were infused with ovine FSH (NIADDK-oFSH-16) for 48 h from the initiation of luteolysis with cloprostenol. Doses of 2.5 or 5 micrograms/h which partly or completely prevented the normal preovulatory decline in plasma FSH concentrations caused a significant increase in mean ovulation rates. Ovulation rates were not increased significantly if the FSH (5 micrograms/h) was infused for only 20 h starting from the initiation of luteolysis or 24 h later. Infusion of a less potent and relatively impure preparation of FSH (i.e. FSH-P) at 0.5 mg/h for 48 h after cloprostenol treatment also increased the mean ovulation rate significantly. However, if the FSH-P was given for only the first 24 h, or if the start of the infusion was delayed for more than 12 h, mean ovulation rates were not increased significantly. Infusion of LH (NIADDK-oLH-25, 5 micrograms/h) for 48 h from the initiation of luteolysis decreased the mean ovulation rate significantly. Administration of bovine follicular fluid to suppress plasma FSH concentrations below normal during the first 24 h after cloprostenol injection did not delay oestrus. However, oestrus was delayed by approximately 2 days if plasma FSH concentrations were reduced by bovine follicular fluid 24 h after the initiation of luteolysis. As ovulation rate increased, the mean weight of individual corpora lutea of each ewe decreased. In ewes with a single ovulation, most corpora lutea weighed greater than 600 mg, but as the ovulation rate increased the proportion of corpora lutea present weighing less than 400 mg rose steadily.(ABSTRACT TRUNCATED AT 250 WORDS)
mesh_terms: D000818:Animals; D001826:Body Fluids / Q000378:metabolism; D003008:Cloprostenol / Q000494:pharmacology; D003338:Corpus Luteum / Q000033:anatomy & histology; D004971:Estrus; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood* / Q000494:pharmacology; D005498:Follicular Phase / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000494:pharmacology; D003341:Luteolysis; D006080:Ovarian Follicle / Q000378:metabolism; D010060:Ovulation / Q000187:drug effects*; D012756:Sheep
chemical_list: D003008:Cloprostenol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone